FDA-cleared K252922
Neosoma Brain Mets
Neosoma, Inc.
Neosoma Brain Mets semi-automatically segments and contours previously diagnosed brain metastases on T1 post-contrast brain MRI to support radiation-oncology treatment planning.
- Modality
- MRI
- Anatomy
- Brain; previously diagnosed brain metastases
- Decision
- 2025-12-17